Cardionomic Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 14
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $5M
Latest Deal Amount
  • Investors
  • 4

Cardionomic General Information

Description

Developer of a cardiac therapy intended to treat acute decompensated heart failure. The company's treatments address the condition's root cause of reduced contractility using neuromodulation to increase contractility, improve cardiac output, and increase renal flow or end-organ perfusion, enabling healthcare practitioners to decrease negative hormonal signaling and improve in-hospital morbidity and mortality.

Contact Information

Website
www.cardionomicinc.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Therapeutic Devices
Surgical Devices
Primary Office
  • 601 Campus Drive
  • Suite 12
  • New Brighton, MN 55112
  • United States
+1 (651) 000-0000

Cardionomic Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardionomic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 04-Oct-2021 $5M 000.00 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series A2) 21-Feb-2020 000.00 000.00 000.00 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series A1) 30-Apr-2018 000 000.00 000.00 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 02-Oct-2015 $20M $22.4M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 01-Apr-2014 $2.35M $2.35M Completed Clinical Trials - Phase 1
To view Cardionomic’s complete valuation and funding history, request access »

Cardionomic Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A2 (NV) 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00
Series A1 (NV) 5,439,215 $0.001000 $0.12 $1.47 $1.47 1x $1.47 0%
Series A1 18,786,541 $0.001000 $0.13 $1.63 $1.63 1x $1.63 46.63%
To view Cardionomic’s complete cap table history, request access »

Cardionomic Patents

  • 56

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 5

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Cardionomic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3137307-A1 Systems and methods for denoising physiological signals during electrical neuromodulation Pending 06-May-2019 0000000000
AU-2020269601-A1 Systems and methods for denoising physiological signals during electrical neuromodulation Pending 06-May-2019 0000000000
EP-3836859-A1 Systems and methods for affecting cardiac contractility and/or relaxation Pending 13-Aug-2018 0000000000
AU-2019320750-A1 Systems and methods for affecting cardiac contractility and/or relaxation Pending 13-Aug-2018 00000000000
CA-3107959-A1 Systems and methods for affecting cardiac contractility and/or relaxation Pending 13-Aug-2018 A61B18/1492
To view Cardionomic’s complete patent history, request access »

Cardionomic Executive Team (4)

Name Title Board Seat Contact Info
Steve Goedeke Founder, Chief Executive Officer, President & Board Member
Todd Kerkow Chief Technology Officer
Michelle Kennefick Vice President of Clinical Research
You’re viewing 3 of 4 executive team members. Get the full list »

Cardionomic Board Members (16)

Name Representing Role Since
Ali Behbahani MD New Enterprise Associates Board Member 000 0000
Andrew Senn Self Board Member 000 0000
Anthony Borowicz Integer Board Member 000 0000
Brian Farley Self Board Member 000 0000
Jon Friedland Self Board Member 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Cardionomic Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cardionomic Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cleveland Clinic Ventures Corporate Venture Capital Minority 000 0000 000000 0
Ascension Ventures Corporate Venture Capital Minority 000 0000 000000 0
Integer Corporation Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0
To view Cardionomic’s complete investors history, request access »

Ready to get started?

Request a free trial